IFNA2 and Miyoshi myopathy: However, with regards to MM, several free cytokines such as interferon-alpha (IFNα) and TNF-related apoptosis-inducing ligand (TRAIL) have been extensively studied as a treatment modality because of their known anti-MM effects in preclinical models (148–151).